Clinical trial
Androgen Deprivation Therapy in Treating Patients With Prostate Cancer
NCT00110162 · Peter MacCallum Cancer Centre, Australia, Other · Unknown status
Key facts
| NCT number | NCT00110162 |
|---|---|
| Title | Androgen Deprivation Therapy in Treating Patients With Prostate Cancer |
| Official title | A Collaborative Randomized Phase III Trial: The Timing of Intervention With Androgen Deprivation in Prostate Cancer Patients With Rising PSA |
| Lead sponsor | Peter MacCallum Cancer Centre, Australia, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Procedure |
| Interventions | antiandrogen therapy, releasing hormone agonist therapy, orchiectomy |
| Enrollment | 2,000 |
| Start date | Oct 1, 2004 |
| Primary completion | Dec 1, 2009 |
| First posted | May 4, 2005 |
| Last update posted | Aug 7, 2013 |
| Countries | Australia, New Zealand |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: